Heart Failure and Aortic Stenosis Transcriptome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-05-30

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is aimed to investigate the global transcriptome in order to determine the expression profile of messenger RNAs (mRNAs), as well as long noncoding- (lncRNAs) and micro noncoding-RNAs (miRNAs) in heart failure (HF) and in aortic stenosis (AS). The aim is to clarify their role in cardiac disease pathogenesis, as well as their potential as biomarkers. To this purpose, both tissue and blood specimens will be collected and patients will be compared to individuals not affected by cardiovascular diseases.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

RNA as Prognostic Biomarkers in Patients With Acute Coronary Syndrome

NCT06058182

Coronary Syndrome

RECRUITING

Biomarkers in Aortic Stenosis - B.A.S.S.

NCT01334801

Aortic Stenosis Disorder of Prosthetic Cardiac Valve Aortic Valve Insufficiency +3 more

COMPLETED

Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure

NCT05573997

Cardiovascular Diseases Heart Failure Valvular Heart Disease +1 more

RECRUITING

Bace1as Role in Heart Failure (BACE1AS-HF)

NCT06213493

Heart Failure Acute Coronary Syndrome

COMPLETED

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

NCT06813443

Cardiomyopathies Amyloidosis Cardiac Fabry Disease +14 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will collect plasma and cardiac tissue specimens from consenting subjects. The investigators will evaluate the expression of mRNAs, miRNAs and lncRNAs in patients affected by both end-stage and not end-stage HF as well as in patients affected by aortic stenosis and undergoing valve replacement and requiring cardiac myectomy. The tissue dysregulated RNAs will be next measured in plasma samples in order to clarify their potential as biomarkers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Aortic Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non end-stage heart failure

Measurement of RNAs in non end-stage heart failure patients undergoing to left ventricle reconstruction